Specialized AI agents improve clinical trial design risk assessment

TrialAtlas coordinates domain-specific agents and historical regulatory evidence to identify design deficiencies, suggest improvements, and estimate development success.

Top University
Jiacheng Lin · Zifeng Wang · Zheng Chen · Erick Scott · Ziwei Yang · Fanyang Yu · +2 more

University of Illinois Urbana-Champaign · Keiji AI Inc · The University of Osaka · University of Pennsylvania · AbbVie Inc

Research Digest··2 min read
Lin et al.

The authors developed TrialAtlas, a research system whose specialized agents gather and synthesize evidence for clinical development planning.

Why this paper

From University of Pennsylvania and 5 others · Part of Multi-Agent Coordination, now 24 papers

In one line

A multi-agent system that coordinates specialized AI agents to detect clinical trial design flaws and predict regulatory success matches or beats current methods.

What we could check

  • ·No code link found
  • ·No weights link found
  • ·No dataset link found
  • ·No compute details found
  • ·No stated limitations found
  • ·No benchmark numbers found

Observed from the paper text and links we have. Absence here means we did not find it, not that it does not exist.

§
newspaper

Research Digest

Articles published under the Zotpaper byline are synthesized from multiple source publications by our AI editor and reviewed by our editorial process. Each story combines reporting from credible outlets to give readers a balanced, comprehensive view.